Login / Signup

Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39-R43 of β2-glycoprotein I.

Marc MoghbelAline RothDaniela BaptistaKapka MitevaFabienne BurgerFabrizio MontecuccoNicolas VuilleumierFrançois MachKarim J Brandt
Published in: Research and practice in thrombosis and haemostasis (2022)
We identified a peptide that selectively bound immunoglobulin G (IgG) derived from APS patients with 100 times more affinity than β2GP1, Domain I, or epitope R39-R43. This peptide is able to inhibit the activity of IgG derived from APS patients in vitro. We have also generated a monoclonal IgG antibody against this peptide. Using both peptide and monoclonal antibody, we have been able to develop a fully standardized indirect colorimetric immunoassay with highly sensitivity. The identification of the optimized peptide offers a new standardized and accurate tool for diagnostics of APS. Furthermore, having increased affinity for aPL, this peptide could represent a useful tool as prevention strategy for APS and an alternative to the use of anticoagulants.
Keyphrases
  • monoclonal antibody
  • end stage renal disease
  • gold nanoparticles
  • systemic lupus erythematosus
  • chronic kidney disease
  • sensitive detection
  • hydrogen peroxide
  • patient reported outcomes